A research paper published in August 2026 evaluated a radiotherapy planning strategy known as 4π for patients with cervical cancer. The aim was to reduce pelvic bone-marrow exposure without compromising tumour coverage.

The researchers combined imaging features, clinical data and dosimetric parameters in machine-learning models. They then compared conventional radiotherapy plans with non-coplanar plans optimised using 4π planning.

What did they observe?

In the analysis, 4π planning reduced several measures of dose delivered to the pelvic bones. The predictive model estimated a reduction in the risk of acute haematological toxicity, although this was an estimate based on retrospective data.

A research direction, not a new standard

The results are promising but require further clinical validation before broader adoption. The study analysed retrospective data from 114 patients and used predictive models, so the findings alone do not prove a clinical reduction in complications for future patients.

Source: Feng H. et al., arXiv:2608.12656, August 2026.